Skip to main content

Table 1 Clinical and biological characteristics of SSc patients

From: Echocardiographic follow-up of patients with systemic sclerosis by 2D speckle tracking echocardiography of the left ventricle

  Systemic sclerosis (n = 19)
Age, (years) 55.2 ± 10.8
Sex (female), [n (%)] 13 (68.4%)
Disease duration, (years) 60 ± 4.5
Time of follow-up examination after baseline examination, (days) 756.6 ± 8.8
Time of baseline echocardiography between right heart catheter, (days) 6.0 ± 10.4
Body mass index (kg/m2) 24.0 ± 2.7
Arterial hypertension, [n (%)] 4 (21.1)
Smoker, [n (%)] 2 (10.5)
Raynaud’s syndrom, [n (%)] 8 (42.1)
Modified Rodnan Skin Score 8.2 ± 6.5
Anti-centromere antibodies, [n (%)] 4 (21.1)
Anti-Scl-70 antibodies, [n (%)] 7 (36.8)
Pulmonary fibrosis, [n (%)] 8 (42.1)
Impaired renal function, [n (%)] 2 (10.5)
       Invasive measurements
Cardiac output, (l/min) 5.4 ± 0.7
Cardiac index, (l/min/m2) 3.0 ± 0.4
PAP systolic, (mmHg) 27.3 ± 4.9
PAP diastolic, (mmHg) 11.2 ± 3.1
PAP mean, (mmHg) 17.7 ± 3.5
PCWP mean, (mmHg) 10.1 ± 3.6
SVR, (dyn × sec × cm-5) 2203.3 ± 787.7
PVR, (dyn × sec × cm-5) 188.3 ± 98.6
  1. Data are expressed as mean ± SD, except gender, hypertension, and except disease duration and time of follow-up examination, which are expressed as median ± SD. SSc, systemic sclerosis; PAP, pulmonary artery pressure; PCWP, pulmonary capillary wedge pressure; SVR, systemic vascular resistance; PVR, pulmonary vascular resistance.